Growth phase of orally administered Lactobacillus strains differentially affects IgG1/IgG2a ratio for soluble antigens: implications for vaccine development

CBM (Kitty) Maassen; WJA Boersma; JCPA Holten-Neelen; Eric Claassen; Jon Laman

doi:10.1016/S0264-410X(03)00220-2

Growth phase of orally administered Lactobacillus strains differentially affects IgG1/IgG2a ratio for soluble antigens: implications for vaccine development

CBM (Kitty) Maassen, WJA Boersma, JCPA Holten-Neelen, Eric Claassen, Jon Laman

Immunology

Research output: Contribution to journal › Article › Academic › peer-review

78 Citations (Scopus)

14 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	2751-2757
Number of pages	7
Journal	Vaccine
Volume	21
DOIs	https://doi.org/10.1016/S0264-410X(03)00220-2
Publication status	Published - 2003

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S0264-410X(03)00220-2

1-s2.0-S0264410X03002202-main.pdfFinal published version, 112 KB
1-s2.0-S0264410X03002202-main.pdfFinal published version, 112 KB

http://hdl.handle.net/1765/73397

Cite this

@article{5ec71d6f8c774c058255538b9339c088,

title = "Growth phase of orally administered Lactobacillus strains differentially affects IgG1/IgG2a ratio for soluble antigens: implications for vaccine development",

author = "Maassen, {CBM (Kitty)} and WJA Boersma and JCPA Holten-Neelen and Eric Claassen and Jon Laman",

year = "2003",

doi = "10.1016/S0264-410X(03)00220-2",

language = "Undefined/Unknown",

volume = "21",

pages = "2751--2757",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier",

}

TY - JOUR

T1 - Growth phase of orally administered Lactobacillus strains differentially affects IgG1/IgG2a ratio for soluble antigens: implications for vaccine development

AU - Maassen, CBM (Kitty)

AU - Boersma, WJA

AU - Holten-Neelen, JCPA

AU - Claassen, Eric

AU - Laman, Jon

PY - 2003

Y1 - 2003

U2 - 10.1016/S0264-410X(03)00220-2

DO - 10.1016/S0264-410X(03)00220-2

M3 - Article

SN - 0264-410X

VL - 21

SP - 2751

EP - 2757

JO - Vaccine

JF - Vaccine

ER -